Pieces vs Regard
Two physician founded platforms reading the inpatient chart, and one of them has already been through the thing every buyer in this category quietly worries about. In September 2024 the Texas Attorney General settled with Pieces over its accuracy claims, the first enforcement action of its kind in healthcare AI, which is both a genuine mark against the vendor and the only instance here of an outside authority examining what a clinical AI company says about its own performance. Regard has no such history and also no published accuracy figure, model description or validation study, while doing the more consequential thing: recommending diagnoses rather than summarising. Pieces is the better answer for case management and utilisation review, which nothing else here addresses. Regard is the better answer at the bedside, with certified interoperability and an acceptance rate it actually reports.
- It is the only product in this category that explicitly addresses case management and utilisation review rather than only the clinician, which is where a large share of the reading burden in a hospital actually sits.
- The oversight architecture is more developed than most of this category and it was built under scrutiny rather than in the abstract, which is worth weighing alongside the enforcement history rather than instead of it.
- It now sits inside a group that publishes a genuine trust centre with named compliance items, which is a stronger assurance position than the product had standing alone.
- It recommends diagnoses rather than summarising, on the stated premise that clinicians see roughly 3 percent of the data in a chart, and the clinician accepts or declines each recommendation as a structural gate.
- Certified interoperability rather than claimed, as an ONC certified health information technology module implementing the modern exchange standard, with named health system deployments and quantified site level results.
- Its own headline metric is the count of recommendations clinicians acted on, which is an acceptance rate rather than an adoption figure, and it is one of the few numbers in this category that describes whether the output was useful.
Side by Side
| Axis | P Pieces |
R Regard |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
In September 2024 the Texas Attorney General reached a settlement with Pieces over its accuracy claims, the first enforcement action of its kind against a healthcare AI vendor. That is a matter of public record and it cuts both ways: it is a real accuracy governance failure, and it also means this vendor's claims have been examined by an external authority in a way no competitor's have. Read the settlement terms rather than the headline.
Regard publishes no model description, accuracy figure, validation publication or error taxonomy, and its regulatory credential examines record system criteria rather than diagnostic performance. Both vendors surface undocumented diagnoses that raise reimbursement as well as clinical completeness, and neither separates the two effects.